West, D.X., Ives, J.S., Krejci, J., Salberg, M.M., Zumbahlen, T.L., Bain, G.A., Liberta, A.E., Valdes-Martinez, J., Hernandez-Ortiz, S. and Toscano, R.A. (1995) Copper (II) Complexes of 2-Benzoylpyridine 4N-Substituted Thiosemicarbazones. Polyhedron, 14, 2189-2200.
http://dx.doi.org/10.1016/0277-5387(95)00010-P

has been cited by the following article:

• TITLE: Cu(II) Benzoylpyridine Thiosemicarbazone Complexes: Inhibition of Human Topoisomerase IIα and Activity against Breast Cancer Cells

  AUTHORS: Jennifer D. Conner, Wathsala Medawala, Madison T. Stephens, William H. Morris, Joseph E. Deweese, Patrick L. Kent, Jeffery J. Rice, Xiaohua Jiang, Edward C. Lisic

  KEYWORDS: Topoisomerase IIα, Alpha-(N)-Heterocyclic Thiosemicarbazones, Breast Cancer Cells

  JOURNAL NAME: Open Journal of Inorganic Chemistry, Vol.6 No.2, April 29, 2016

  ABSTRACT: The focus of this research is on the study of a series of copper (II) benzoylpyridine thiosemicarbazone complexes. Of the six benzoylpyridine thiosemicarbazone ligands used in this study, two are reported for the first time; 2-benzoylpyridine tert-butyl thiosemicarbazone (BZP-tBTSC), and 2-benzoylpyridine benzyl thiosemicarbazone (BZP-BzTSC). Once characterized by NMR, melting point, and MS, these mono-anionic tridentate ligands were then reacted with Cu2+ to form the new square planar metal complexes [Cu(BZP-tBTSC)Cl] and [Cu(BZP-BzTSC)Cl]. All of the copper complexes display marked inhibition of human topoisomerase IIα. The [Cu(BZP-tBTSC)Cl] complex shows marked activity against human breast cancer cell lines.